Procter & Gamble Health Limited Market Cap ($1.05 Billion)
Market Cap & Net Worth: Procter & Gamble Health Limited (PGHL)
Procter & Gamble Health Limited market cap. Procter & Gamble Health Limited (NSE:PGHL) has a market capitalization of $1.05 Billion (Rs97.26 Billion) as of November 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #8347 globally and #412 in its home market, demonstrating a 15.88% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Procter & Gamble Health Limited's stock price Rs5859.00 by its total outstanding shares 16599382 (16.60 Million). Also see Procter & Gamble Health Limited (PGHL) cash flow conversion for how efficiently the company converts equity into cash flow.
Procter & Gamble Health Limited Market Cap History (2015–2026)
Procter & Gamble Health Limited market cap history from 2015 to 2026. Data shows growth from $111.38 Million to $1.05 Billion (22.21% CAGR). Check Procter & Gamble Health Limited stock price for real-time trading data and today's change.
Index Memberships
Procter & Gamble Health Limited is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY MIDSMALLCAP 400
NIFTYMIDSML400
|
$1.09 Trillion | 0.10% | #229 of 400 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.10 Trillion | 0.03% | #341 of 750 |
Weight: Procter & Gamble Health Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Procter & Gamble Health Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Procter & Gamble Health Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Procter & Gamble Health Limited (PGHL) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.08x
Procter & Gamble Health Limited's market cap is 0.08 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.37x
Procter & Gamble Health Limited's market cap is 0.37 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $144.92 Million | $9.93 Billion | $791.30 Million | 0.01x | 0.18x |
| 2017 | $191.04 Million | $6.98 Billion | $939.10 Million | 0.03x | 0.20x |
| 2018 | $459.47 Million | $8.49 Billion | $8.39 Billion | 0.05x | 0.05x |
| 2019 | $719.69 Million | $8.89 Billion | $1.66 Billion | 0.08x | 0.43x |
| 2020 | $1.13 Billion | $10.09 Billion | $1.77 Billion | 0.11x | 0.64x |
| 2020 | $1.13 Billion | $11.55 Billion | $2.05 Billion | 0.10x | 0.55x |
| 2021 | $900.80 Million | $11.14 Billion | $1.93 Billion | 0.08x | 0.47x |
| 2022 | $675.17 Million | $12.30 Billion | $2.29 Billion | 0.05x | 0.29x |
| 2023 | $869.99 Million | $11.51 Billion | $2.01 Billion | 0.08x | 0.43x |
| 2024 | $940.31 Million | $12.18 Billion | $2.51 Billion | 0.08x | 0.37x |
Competitor Companies of PGHL by Market Capitalization
Companies near Procter & Gamble Health Limited in the global market cap rankings as of November 4, 2026. Also see Procter & Gamble Health Limited (PGHL) total assets for a full breakdown of the balance sheet.
Key companies related to Procter & Gamble Health Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #534 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #580 globally with a market cap of $46.03 Billion USD ( CN¥314.55 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #509 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #534 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.90 |
| #580 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.03 Billion | CN¥49.31 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Procter & Gamble Health Limited (2015–2026)
Market capitalization of Procter & Gamble Health Limited from 2015 to today. Between 2015 and today, Procter & Gamble Health Limited's market cap moved from $111.38 Million to $ 1.05 Billion, with a yearly change of 22.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs1.05 Billion | +2.74% |
| 2025 | Rs1.02 Billion | +8.88% |
| 2024 | Rs940.31 Million | +8.08% |
| 2023 | Rs869.99 Million | +28.86% |
| 2022 | Rs675.17 Million | -25.05% |
| 2021 | Rs900.80 Million | -20.39% |
| 2020 | Rs1.13 Billion | +57.23% |
| 2019 | Rs719.69 Million | +56.63% |
| 2018 | Rs459.47 Million | +140.52% |
| 2017 | Rs191.04 Million | +31.82% |
| 2016 | Rs144.92 Million | +30.11% |
| 2015 | Rs111.38 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Procter & Gamble Health Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.05 Billion USD |
| MoneyControl | $1.05 Billion USD |
| MarketWatch | $1.05 Billion USD |
| marketcap.company | $1.05 Billion USD |
| Reuters | $1.05 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Procter & Gamble Health Limited
Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemical products in India and internationally. The company offers over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Polybion, Cosome, Evion, Neurobion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter … Read more